BKWO yields 0.60% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, BKWO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKWO + PFE for your $10,000?
The fund seeks long-term capital growth, and looks to invest principally in U.S. companies that have attractive financial attributes and promote "women's opportunities" - opportunities that can enhance the professional development and advancement of women and/or the ability of women to meet their work or other personal life responsibilities. The fund considers companies that promote women's opportunities to be companies that demonstrate gender equity practices in the workplace and/or that provide products or services that are believed to enhance the lives of women, including female participation in management and board representation, positive benefit programs including family leave and flexible work arrangements, as well as companies that offer products /services that help women meet daily life needs. Provides investors with a growth-oriented investment with the added focus on gender equality and supporting women's opportunities. BNY Mellon ETF Investment Adviser, LLC will make contributions to one or more charitable organizations which seeks to promote opportunities for women and/or girls, in an amount representing at least 10% annually of the management fee. Liquid ETF structure allows investors to buy or sell any time the market is open.
Full BKWO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.